Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Albert David Limited

Market Cap 3.35B 35.25M 30.44M 28.05M 26.26M 49.21M 49.97M 331M 129M 1.63B 132M 129M 5.65B P/E Ratio 2024
8.14x
P/E Ratio 2025 26.9x
Enterprise Value 1.04B 10.91M 9.42M 8.68M 8.13M 15.23M 15.46M 103M 39.96M 505M 40.93M 40.06M 1.75B EV / Sales 2024
0.92x
EV / Sales 2025 0.67x
Free-Float
35.96%
Yield 2024
1.07%
Yield 2025 0.62%
1 day-0.59%
1 week+1.49%
Current month+1.82%
1 month+2.48%
3 months+6.64%
6 months-6.35%
Current year-2.07%
1 week 686.5
Extreme 686.5
737.95
1 month 683.5
Extreme 683.5
737.95
Current year 579.9
Extreme 579.9
819.6
1 year 579.9
Extreme 579.9
957.5
3 years 579.9
Extreme 579.9
1,753.95
5 years 472.1
Extreme 472.1
1,753.95
10 years 263
Extreme 263
1,753.95
Manager TitleAgeSince
Chief Executive Officer 52 2026-05-11
Director of Finance/CFO - 2020-11-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 72 2009-12-29
Director/Board Member 68 2014-03-30
Director/Board Member 64 2020-08-23
Change 5-day change 1-year change 3-year change Capi.($)
-0.59%+1.49% - - 43.61M
-0.09%+1.34%+7.00%+83.03% 45.63B
+0.29%-3.31%+41.08%+82.87% 33.53B
-0.58%-1.43%-8.23%+41.14% 11.81B
-1.50%-0.08%+11.61%+104.40% 11.69B
+1.95%+0.78%+36.70%+129.46% 9.12B
+1.59%-0.16%+20.72%+44.63% 7.16B
+2.37%+1.80%+45.10%-15.41% 6.49B
-0.79%-0.44%+29.15%+238.32% 6.45B
+0.06%-2.97%-43.02%-3.42% 5.16B
Average +0.27%-0.16%+15.57%+78.34% 15.23B
Weighted average by Cap. +0.15%-0.32%+18.08%+81.69%

Financials

2024 2025
Net sales 3.62B 38.13M 32.94M 30.35M 28.41M 53.24M 54.07M 358M 140M 1.76B 143M 140M 6.11B 3.46B 36.38M 31.42M 28.95M 27.1M 50.79M 51.58M 342M 133M 1.68B 137M 134M 5.83B
Net income 754M 7.93M 6.85M 6.32M 5.91M 11.08M 11.25M 74.57M 29.07M 367M 29.78M 29.15M 1.27B 172M 1.81M 1.56M 1.44M 1.35M 2.53M 2.57M 17.01M 6.63M 83.72M 6.79M 6.65M 290M
Net Debt -2.82B -29.66M -25.62M -23.6M -22.1M -41.41M -42.05M -279M -109M -1.37B -111M -109M -4.75B -2.31B -24.34M -21.02M -19.37M -18.13M -33.98M -34.51M -229M -89.18M -1.13B -91.34M -89.4M -3.9B
Logo Albert David Limited
Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.
Employees
1,805
Date Price Change Volume
26-06-15 721.35 -0.59% 4,188
26-06-12 725.60 +4.43% 7,757
26-06-11 694.85 -0.79% 2,851
26-06-10 700.40 +0.61% 784
26-06-09 696.15 +0.69% 2,132
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!